Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Dana Yehudai‐Ofir"'
Autor:
Israel Henig, Jonathan Isenberg, Dana Yehudai-Ofir, Ronit Leiba, Shimrit Ringelstein-Harlev, Ron Ram, Batia Avni, Odelia Amit, Sigal Grisariu, Tehila Azoulay, Ilana Slouzkey, Tsila Zuckerman
Publikováno v:
Vaccines, Vol 11, Iss 4, p 775 (2023)
COVID-19-related mortality among hematopoietic stem cell transplantation (HSCT) recipients in the pre-vaccine era ranged between 22 and 33%. The Pfizer/BioNTech BNT162b2 vaccine demonstrated significant immunogenicity and efficacy in the healthy popu
Externí odkaz:
https://doaj.org/article/94348d0ee029449fa530060c7aaf3ce8
Publikováno v:
Haematologica, Vol 106, Iss 4 (2020)
Outcomes of allogeneic hematopoietic stem cell transplantation (allo- HSCT) have improved in the recent decade; however, infections and graft-versus-host disease remain two leading complications significantly contributing to early transplant-related
Externí odkaz:
https://doaj.org/article/2186c6dfa1584ec3bfa1df86bebb04fd
Autor:
Ofrat Beyar Katz, Chava Perry, Sigal Grisariu‐Greenzaid, Dana Yehudai‐Ofir, Efrat Luttwak, Batia Avni, Tsila Zuckerman, Inbal Sdayoor, Polina Stepensky, Shimrit Ringelstein‐Harlev, Yael Bar‐On, Diana Libster, Liat Sharvit, Odelia Amit, Uri Greenbaum, Ronit Gold, Yair Herishanu, Noam Benyamini, Irit Avivi, Ron Ram
Publikováno v:
European Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68913e150ac552a059e5cb08a67beca5
https://doi.org/10.1111/ejh.13968
https://doi.org/10.1111/ejh.13968
Autor:
Laila Nassar, Yael Lurie, Edna Efrati, Inna Scherb, Daniel Kurnik, Tsila Zuckerman, Israel Henig, Tareq Artul, Dana Yehudai-Ofir
Publikováno v:
Therapeutic Drug Monitoring. 44:414-418
BACKGROUND Busulfan (Bu) conditioning used in hematopoietic stem cell transplantation (HSCT) may induce seizures, and prophylactic antiepileptic treatment is recommended. Following updated guidelines, in August 2019, the adult HSCT department of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfba8d567841931d243052ee692ae10f
https://doi.org/10.1097/ftd.0000000000000938
https://doi.org/10.1097/ftd.0000000000000938
Autor:
Ofrat Beyar-Katz, Chava Perry, Yael Bar-On, Sigal Grisariu, Dana Yehudai-Ofir, Efrat Luttwak, Batia Avni, Tsila Zuckerman, Inbal Sdayoor, Polina Stepensky, Shimrit Ringelstein-Harlev, Diana Libster, Liat Sharvit, Odelia Amit, Uri Greenbaum, Ronit Gold, Yair Herishanu, Noam Benyamini, Irit Avivi, Ron Ram
Chimeric antigen receptor T-cells (CAR-T) are widely used for the treatment of relapsed/refractory Diffuse large B cell lymphoma (DLBCL). The data for CAR-T cell therapy in patients with extra-nodal(EN) lymphoma is restricted. We included 126 consecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5855462c6ce33322e2ba406612a76c9f
https://doi.org/10.21203/rs.3.rs-2262627/v1
https://doi.org/10.21203/rs.3.rs-2262627/v1
Publikováno v:
Acta Haematologica. 144:683-687
Pure red cell aplasia (PRCA) can potentially occur after allogeneic hematopoietic stem cell transplantation (allo-HSCT) if recipient and donor ABO blood groups are mismatched, with the recipient having isoagglutinins against the donor blood group. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b85ec5b8a478e408c38bb9149f4cd2ad
https://doi.org/10.1159/000515257
https://doi.org/10.1159/000515257
Autor:
Sigal Grisariu Greenzaid, Ron Ram, Mona Kazuli, Dana Yehudai-Ofir, Liat Shargian, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Yael Bar-On, Eran Zimran, Adir Shaulov, Polina Stepensky, Jacob Strahilevitz, Batia Avni
Publikováno v:
Blood. 140:12833-12834
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c66df69b6f7ad175477c215fde1187b6
https://doi.org/10.1182/blood-2022-164694
https://doi.org/10.1182/blood-2022-164694
Autor:
Ofrat Beyar Katz, Chava Perry, Efrat Luttwak, Inbal Sdayoor, Yael Bar-On, Odelia Amit, Ronit Gold, Yair Herishanu, Noam Benyamini, Sigal Grisariu Greenzaid, Batia Avni, Polina Stepensky, Diana Libster, Dana Yehudai-Ofir, Shimrit Harlev, Liat Sharvit, Tsila Zuckerman, Uri Greenbaum, Irit Avivi, Ron Ram
Publikováno v:
Blood. 140:3816-3817
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5de1792fde1256f866327906e594f78
https://doi.org/10.1182/blood-2022-165149
https://doi.org/10.1182/blood-2022-165149
Autor:
Riva Fineman, Dvora Sahar, Nivin Moustafa-Hawash, Shimrit Ringelstein-Harlev, Nuhad Haddad, Dana Yehudai-Ofir, Jacob M. Rowe, Yuval Nov, Ofrat Beyar-Katz, Noa Lavi, Yishai Ofran, Tsila Zuckerman, Israel Henig
Publikováno v:
Leukemia & Lymphoma. 60:2449-2456
Autologous stem cell transplantation (ASCT), intensifying anti-leukemic effects without significant treatment-related mortality (TRM), is particularly appealing in AML with favorable genetic/molecular profile. This study retrospectively evaluated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c37d52a38b5d8ec750a0781443a23143
https://doi.org/10.1080/10428194.2019.1594214
https://doi.org/10.1080/10428194.2019.1594214
Publikováno v:
Haematologica
Outcomes of allogeneic hematopoietic stem cell transplantation (allo- HSCT) have improved in the recent decade; however, infections and graft-versus-host disease remain two leading complications significantly contributing to early transplant-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7661aa053b33ca4b6cd27772f946c9c
https://doi.org/10.3324/haematol.2020.247395
https://doi.org/10.3324/haematol.2020.247395